Benefits of azacitidine for treatment of myelodysplastic syndromes

Bookmark and Share
Published: 6 May 2009
Views: 14606
Rating:
Save
Prof Pierre Fenaux - Service d'Hématologie Clinique, Avicenne Hospital / Université Paris, France
Professor Pierre Fenaux, Service d'Hématologie Clinique, Avicenne Hospital / Université Paris, France, discusses the benefits of azacitidine (vidaza) for treatment of myelodysplastic syndromes.